Emerging Scholars Award

The Emerging Scholars Session was created in 2020 to showcase the innovative and cutting-edge research of junior and early career neurologists and neuroscientists. Each session features four presenters selected by the chairs of the Scientific Program Advisory Committee (SPAC) and the Emerging Scholars Session.
Eligibility  

Student, Resident, Trainee, Postdoc Fellow, Assistant Professor & Instructor

Process:

Candidates are selected once all abstracts are reviewed and scored. Abstracts submitted by those in the eligible career categories are sent to the chairs of SPAC and the Emerging Scholars Session. The chairs select four (4) presenters for each session the ANA chooses to have during the Annual Meeting. If the author of the abstract cannot attend and present at the Annual Meeting, the co-author is permitted to present as long as they are a student, resident, trainee, postdoc fellow, undergrad, assistant professor, or instructor.

Prize:

One presenter from each session is eligible for a prize of $250. The recipient is determined by the SPAC committee after the session and based on the scores of each presentation. The presenter with the highest score in each session receives the $250.

 

ANA2021 Emerging Scholar Award Winners

Jason Chua, MD, PhD
Johns Hopkins University
Autophagy & Neurons: Targeting Protein Quality Control for Modifying Proteostasis and Discovering Therapeutic Targets for Neurodegenerative Diseases

 

Nigel Pedersen, MBBS
Emory University
Sleep Disruption in a Mouse Model of Medial Temporal Lobe Epilepsy

 

Daniel Huddleston, MD
Emory University
Imaging Prodromal Neuromelanin and Iron Pathology in REM Sleep Behavior Disorder

 

ANA2020 Emerging Scholar Award Winners

Albert Davis, MD, PhD
Washington University School of Medicine
APOE Genotype Regulates Pathology and Disease Progression in Synucleinopathy

Juliane Gust, MD, PhD
Seattle Children's Research Institute, Center for Integrative Brain Research
In-vivo Two-photon Imaging Reveals Brain Capillary Plugging During Neurotoxicity in a Mouse Model of Chimeric Antigen Receptor (CAR) T Therapy
 

Jennifer Orthmann-Murphy, MD, PhD
University of Pennsylvania
An Undiagnosed White Matter Disorders Neurogenetics Clinic

Xilma Ortiz-Gonzalez, MD, PhD
University of Pennsylvania, Perelman School of Medicine
FTH1 De Novo Dominant Variants Alter Iron Metabolism and Cause a Pediatric Onset Neuroferritinopathy
 

Back to Awards